All posts by: Michael Zand

About Michael Zand

CRISPR, Five Ways – NPR

Continue reading

2017-06-05 NEWS

NPR

CRISPR, Five Ways
NPR
CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is the basis for a revolutionary genome-editing technology that allows researchers to make very precise modifications to DNA. The implications are enormous — not only …

and more »

Continue reading

2017-06-05 NEWS

EurekAlert (press release)

CRISPR tech leads to new screening tool for Parkinson’s disease
EurekAlert (press release)
They are using CRISPR Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) gene-editing technology. The system is one of research’s fastest growing biomedical techniques that allows scientists to make specific changes in the DNA of plants …

Continue reading

2017-06-05 NEWS

A first: All respond to gene therapy in a blood cancer study
ABC News
Doctors are reporting unprecedented success from a new kind of cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small, 35 people, every patient responded to treatment and all but two

and more »

Continue reading

2017-06-05 NEWS

A first: All respond to gene therapy in a blood cancer study
ABC News
Doctors are reporting unprecedented success from a new kind of cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small, 35 people, every patient responded to treatment and all but two

and more »

Continue reading

2017-06-05 NEWS

HalioDx : HalioDx highlights use of Immunosign® to define CAR T-cell therapy signature in tumor at ASCO 2017
GlobeNewswire (press release)
For the first time, a tumor microenvironment immune gene signature associated with CAR T-cell treatment of non-Hodgkin lymphoma (NHL) patients has been described. Data analysis pointed to immune programs which may facilitate or modulate anti-tumor …

Continue reading

2017-06-05 NEWS

HalioDx : HalioDx highlights use of Immunosign® to define CAR T-cell therapy signature in tumor at ASCO 2017
GlobeNewswire (press release)
For the first time, a tumor microenvironment immune gene signature associated with CAR T-cell treatment of non-Hodgkin lymphoma (NHL) patients has been described. Data analysis pointed to immune programs which may facilitate or modulate anti-tumor …

and more »

Continue reading

2017-06-05 NEWS

The Indian Express

New gene therapy may ‘turn off’ asthma
The Indian Express
New gene therapy may ‘turn off’ asthma. The findings showed that the single treatment may give life-long protection from asthma as well as those who have severe allergies to peanuts, bee venom, shell fish and other substances by de-sensitising the
Gene therapy could wipe immune memory and “turn off” severe allergiesNew Atlas
Now, A New Gene Therapy Can “Turn Off” Asthma and Food AllergiesNDTV Food
New gene therapy may ‘turn off’ asthma – The Economic TimesEconomic Times
Times of India –Zee News –BSI bureau (press release)
all 17 news articles »